Technology Assessment Submissions Required Under UK's NICE Timeline
This article was originally published in The Gray Sheet
Manufacturers of autologous cartilage products have six months to assemble clinical and cost-effectiveness data for submission to the UK's National Institute for Clinical Excellence.
You may also be interested in...
Britain's National Institute of Clinical Excellence (NICE) plans to conduct on an annual basis clinical and cost-effectiveness evaluations of between 30 and 50 new and existing medical technologies, Edward Hutt, division director Quintiles Medical Technology Consultants, said March 14.
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.